Searching for the Perfect Homeostasis Five Strains of Bifidobacterium longum from Centenarians Have a Similar Behavior in the Production of Cytokines

Journal of Clinical Gastroenterology

Volumn 50, Issue , 2016, Pages S126-S130

  Nicola, Stefania ^a   Amoruso, Angela ^a   Deidda, Francesca ^a   Pane, Marco ^a   Allesina, Serena ^a   Mogna, Luca ^a   Del Piano, Mario ^b   Mogna, Giovanni ^c  

^a Novara Technology Srl   (Italy)

^b Policlinico di Monza   (Italy)

^c Probiotical SpA   (Italy)

Author keywords

Bifidobacterium; Centenarians; cytokines; immunomodulation; probiotics

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 4; PROBIOTIC AGENT; CYTOKINE; IL17A PROTEIN, HUMAN; IL4 PROTEIN, HUMAN; INTERLEUKIN 12;

AGED; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM LONGUM; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LACTOBACILLUS CASEI; LACTOBACILLUS FERMENTUM; LACTOBACILLUS PARACASEI; LACTOBACILLUS PENTOSUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SALIVARIUS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VERY ELDERLY; BACTERIUM CULTURE; BLOOD; IMMUNE SYSTEM; BIOSYNTHESIS; INTESTINE FLORA; MICROBIOLOGY; MONONUCLEAR CELL; PHYSIOLOGY;

AGED, 80 AND OVER; BIFIDOBACTERIUM LONGUM; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL MICROBIOME; HOMEOSTASIS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-17; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR;

EID: 84995566960     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000678     Document Type: Article

References (44)

1. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9:313-323.
2. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology. 2009;136:65-80.
3. Rondanelli M, Giacosa A, Faliva MA, et al. Review on microbiota and effectiveness of probiotics use in older. World J Clin Cases. 2015;3:156-162.
4. Salminen S, Bouley C, Boutron-Ruault MC, et al. Functional food science and gastrointestinal physiology and function. Br J Nutr. 1998;80(suppl 1):S147-S171.
5. Isolauri E, Majamaa H, Arvola T, et al. Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology. 1993;105: 1643-1650.
6. Kaila M, Isolauri E, Soppi E, et al. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res. 1992;32: 141-144.
7. Kopp-Hoolihan L. Prophylactic and therapeutic uses of probiotics: A review. J Am Diet Assoc. 2001;101:229-238.
8. Marteau PR, de Vrese M, Cellier CJ. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr. 2001;73(S2):430S-436S.
9. López P, Gueimonde M, Margolles A, et al. Distinct Bifidobacterium strains drive different immune responses in vitro. Int J Food Microbiol. 2010;138:157-165.
10. Gionchetti P, Lammers KM, Rizzello F, et al. VSL#3: An analysis of basic and clinical contributions in probiotic therapeutics. Gastroenterol Clin North Am. 2005;34:499-513.
11. Young SL, Simon MA, Baird MA, et al. Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clin Diagn Lab Immunol. 2004;11:686-690.
12. Pena JA, Versalovic J. Lactobacillus rhamnosus GG decreases TNF a production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism. Cell Microbiol. 2003;5:277-285.
13. Gackowska L, Michalkiewicz J, Krotkiewski M, et al. Combined effect of different lactic acid bacteria strains on the mode of cytokines pattern expression in human peripheral blood mononuclear cells. J Physiol Pharmacol. 2006;57:13-21.
14. Fujiwara D, Inoue S, Wakabayashi H, et al. The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance. Int Arch Allergy Immunol. 2004;135:205-215.
15. Mohamadzadeh M, Olson S, Kalina WV, et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci USA. 2005;102:2880-2885.
16. Pochard P, Hammad H, Ratajczak C, et al. Direct regulatory immune activity of lactic acid bacteria on Der p 1-pulsed dendritic cells from allergic patients. J Allergy Clin Immunol. 2005;116:198-204.
17. Hart AL, Lammers K, Brigidi P, et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut. 2004;53:1602-1609.
18. Zeuthen LH, Christensen HR, Frøkiaer H. Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gram-negative bacteria. Clin Vaccine Immunol. 2006;13:365-375.
19. Ogle CK, Guo X, Hasselgren PO, et al. The gut as a source of inflammatory cytokines after stimulation with endotoxin. Eur J Surg. 1997;163:45-51.
20. Isolauri E, Arvola T, Sütas Y, et al. Probiotics in the management of atopic eczema. Clin Exp Allergy. 2000;30: 1604-1610.
21. Arai F, Takahashi T, Furukawa K, et al. Mucosal expression of interleukin-6 and interleukin-8 messenger RNA in ulcerative colitis and in Crohn's disease. Dig Dis Sci. 1998;43:2071-2079.
22. Isolauri E. Probiotics and gut inflammation. Curr Opin Gastroenterol. 1999;15:534-537.
23. Murata Y, Ishiguro Y, Itoh J, et al. The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis. J Gastroenterol. 1995;30(suppl 8):56-60.
24. Kalliomäki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: A randomised placebocontrolled trial. Lancet. 2001;357:1076-1079.
25. Majamaa H, Isolauri E. Probiotics: A novel approach in the management of food allergy. J Allergy Clin Immunol. 1997;99:179-185.
26. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr. 2000;30: 61-67.
27. Harmsen HJ, Raangs GC, He T, et al. Extensive set of 16S rRNA-based probes for detection of bacteria in human feces. Appl Environ Microbiol. 2002;68:2982-2990.
28. Dong P, Yang Y, Wang WP. The role of intestinal bifidobacteria on immune system development in young rats. Early Hum Dev. 2010;86:51-58.
29. Ouwehand AC, Bergsma N, Parhiala R, et al. Bifidobacterium microbiota and parameters of immune function in elderly subjects. Fems Immunol Med Microbiol. 2008;53:18-25.
30. Woodmansey EJ, McMurdo MET, Macfarlane GT, et al. Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and nonantibiotic-treated elderly subjects. Appl Environ Microbiol. 2004;70:6113-6122.
31. Tiihonen K, Ouwehand AC, Rautonen N. Human intestinal microbiota and healthy ageing. Ageing Res Rev. 2010;9:107-116.
32. Saavedra JM, Bauman NA, Oung I, et al. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet. 1994;344:1046-1049.
33. Brady LJ, Gallaher DD, Busta FF. The role of probiotic cultures in the prevention of colon cancer. J Nutr. 2000;130(2S):410S-414S.
34. McCarthy J, O'Mahony L, O'Callaghan L, et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut. 2003;52:975-980.
35. Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut. 2003;52:988-997.
36. Asahara T, Shimizu K, Nomoto K, et al. Probiotic bifidobacteria protect mice from lethal infection with Shiga toxinproducing Escherichia coli O157:H7. Infect Immun. 2004;72:2240-2247.
37. O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128:541-551.
38. Biagi E, Candela M, Fairweather-Tait S, et al. Ageing of the human metaorganism: The microbial counterpart. Age (Dordr). 2012;34:247-267.
39. Biagi E, Nylund L, Candela M, et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One. 2010;5:e10667.
40. Mueller S, Saunier K, Hanisch C, et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: A cross-sectional study. Appl Environ Microbiol. 2006;72:1027-1033.
41. Wang F, Huang G, Cai D, et al. Qualitative and semiquantitative analysis of fecal Bifidobacterium species in Centenarians living in Bama, Guangxi, China. Curr Microbiol. 2015;71:143-149.
42. Drago L, Toscano M, Rodighiero V, et al. Cultivable and pyrosequenced fecal microflora in centenarians and young subjects. J Clin Gastroenterol. 2012;46(suppl):S81-S84.
43. Collino S, Montoliu I, Martin FPJ, et al. Metabolic signatures of extreme longevity in northern Italian Centenarians reveal a complex remodeling of lipids, amino acids, and gut microbiota metabolism. PLoS One. 2013;8:e56564.
44. Sebastiani P, Solovieff N, DeWan AT, et al. Genetic signatures of exceptional longevity in humans. PLoS One. 2012;7:e29848.